2016 RANK: 19
Fiscal year ending: Dec. 31, 2016
R&D Spend: $365,600,000
Daniel Florin, interim CEO, SVP & CFO; Tony Collins, VP, controller & chief accounting officer; Derek Davis, VP, global integration; Robert Delp, president, Americas; William (Bill) Fisher, SVP, global HR; Adrian Furey, SVP, global operations & logistics; Adam Johnson, president, spine, dental, CMF & thoracic; David Kunz, SVP, global quality & regulatory affairs; Dr. Katarzyna Mazur-Hofsaess, president, EMEA; David Nolan, president, biologics, extremities, sports medicine, surgical, trauma, foot & ankle, office-based technologies & Zimmer Biomet signature solutions; Chad Phipps, SVP, general counsel & secretary; Daniel Williamson, president, joint reconstruction; Sang Yi, president, Asia Pacific
Zimmer Biomet has had a hectic year, with 10-year veteran David Dvorak abruptly stepping away from the corner office in July and senior VP and CFO Daniel Florin stepping in until a replacement is found.
Dvorak hasn’t been the only employee to exit the company, which said it “cleaned house” at certain Warsaw-based facilities after receiving a number of violations during an FDA inspection.
The purge included replacing the company’s senior vice president of global operations and logistics, vice president of quality assurance at all of its Warsaw sites, the quality assurance director for its North Campus facilities, the compliance director for the Biomet network, and the quality assurance director for post-market surveillance and complaint handling.